Wordt geladen...
New anti-tuberculosis drugs and regimens: 2015 update
Over 480 000 cases of multidrug-resistant (MDR) tuberculosis (TB) occur every year globally, 9% of them being affected by extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. The treatment of MDR/XDR-TB is unfortunately long, toxic and expensive, and the success rate largely unsat...
Bewaard in:
Gepubliceerd in: | ERJ Open Res |
---|---|
Hoofdauteurs: | , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
European Respiratory Society
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5005131/ https://ncbi.nlm.nih.gov/pubmed/27730131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00010-2015 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|